FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:514-515 August 2, 2007 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: Cetuximab given concurrently with radiotherapy has recently been reported to result in a survival benefit for patients with locally advanced squamous-cell carcinoma of the head and neck, without increasing the toxic effects of radiotherapy.¹ We report two cases of severe radiation dermatitis during the course of radiotherapy for squamous-cell carcinoma of the head and neck with concomitant use of cetuximab; these two cases of dermatitis occurred among five patients treated according to this protocol at our institution.

Patient 1 was a 57-year-old woman with grade 2 squamous-cell carcinoma of the head and neck (cT3cN0cM0), and Patient 2 . . . [Full Text of this Article]

Related Letters:

More on Severe Cutaneous Reaction with Radiotherapy and Cetuximab
Bonner J. A., Ang K., Budach W., Bölke E., Homey B.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:1872-1873, Nov 1, 2007. Correspondence

This article has been cited by other articles:

• Wirth, L. J., Allen, A. M., Posner, M. R., Haddad, R. I., Li, Y., Clark, J. R., Busse, P. M., Chan, A. W., Goguen, L. A., Norris, C. M., Annino, D. J., Tishler, R. B. (2009). Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. Ann Oncol 0: mdp477v1-mdp477 [Abstract] [Full Text]  
• Jatoi, A., Nguyen, P. L. (2008). Do Patients Die from Rashes from Epidermal Growth Factor Receptor Inhibitors? A Systematic Review to Help Counsel Patients About Holding Therapy. The Oncologist 13: 1201-1204 [Abstract] [Full Text]  
• Mielke, F, Schneider-Obermeyer, J, Dorner, T (2008). Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma. Ann Rheum Dis 67: 1056-1057 [Full Text]  
• Gerber, P. A., Enderlein, E., Homey, B. (2008). The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Adverse Effects. JCO 26: 2790-2792 [Full Text]  
• Bonner, J. A., Ang, K., Budach, W., Bolke, E., Homey, B. (2007). More on Severe Cutaneous Reaction with Radiotherapy and Cetuximab. NEJM 357: 1872-1873 [Full Text]